|
출처 시킹 알파
가이던스 인상
배당금 인상 발표
뜬금없이 왜 애브비 가져왔냐고 물어보신다면 제가 평단 111.1 에 물려있기 때문이죠
놀랍게도 사자마자 ........할말을 잃은 ..
-
AbbVie (NYSE:ABBV): Q3 Non-GAAP EPS of $3.33 beats by $0.11; GAAP EPS of $1.78 misses by $0.22.
-
Revenue of $14.34B (+11.2% Y/Y) beats by $40M.
-
Raises 2021 GAAP Diluted EPS Guidance Range from $6.04 to $6.14 to $6.29 to $6.33; Raises 2021 Adjusted Diluted EPS Guidance Range from $12.52 to $12.62 to $12.63 to $12.67 vs. $12.57 consensus.
-
Announces 2022 Dividend Increase of 8.5 Percent, Beginning with Dividend Payable in February 2022.
| 
등록안내
등록안내
프리장 112넘네요 ㄷㄷㄷ